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Abstract
The role of the phospholemman (PLM) on the efflux of taurine and chloride induced by swelling was studied in HEK293
cells overexpressing stable transfected PLM. PLM, a substrate for protein kinases C and A, is a protein that induces an anion
current in Xenopus oocytes and forms taurine-selective channels in lipid bilayers. Taurine contributes as an osmolyte to
regulatory volume decrease (RVD) and is highly permeable through PLM channels in bilayers. In PLM-overexpressing cells
the process of RVD was more rapid and efficient (75%) than in control cells (44%). Also, [3H]taurine and 125I efflux induced
by hyposmolarity were markedly increased (30^100%) in two subclones of cells overexpressing PLM. This increased efflux
was sensitive to the Cl channel blockers DDF, NPPB and DIDS. Acute treatment of control cells with isoproterenol and
norepinephrine induced a significant potentiation (50^60%) of [3H]taurine release induced by hyposmolarity. In PLM-
overexpressing cells the potentiation by these drugs was higher (100%). Insulin induced also an increase in [3H]taurine
release, but only in PLM-overexpressing cells (50%). These results indicate that PLM may play a role in the RVD and that its
phosphorylation may have a physiological significance during this process. The mechanisms involved in this process could
include the activation of PLM itself as channel or the modulation of other preexisting channels. ß 2000 Elsevier Science
B.V. All rights reserved.
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1. Introduction
Taurine is part of the pool of organic molecules
serving a role as osmolytes in animal cells [1^3].
Upon swelling in hyposmotic conditions, taurine ef-
£ux activates through a leak pathway [3^5]. The os-
mosensitive taurine e¥ux is markedly inhibited by a
variety of chloride channel blockers, which led to the
proposal of a common anion channel-like molecule
as the pathway for anions, taurine and other amino
acids functioning as osmolytes [4,6^8]. The molecular
identity of this pathway has not been established.
Some of the channels suggested to function as possi-
ble anion pathways activated by changes in volume
include chloride channels like CLC2 and CLC3, the
anion exchanger band 3 and porins. Other molecules
such as Icln and P-glycoprotein may function as reg-
ulators of the osmosensitive anion pathway. More
recently, phospholemman (PLM) has been added to
the list of possible channels or channel regulators
involved in the transport of chloride and taurine,
with a possible implication on the mechanisms of
cell volume control [9^13].
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PLM is a 72 amino acid protein with a single
membrane-spanning domain and an intracellular
C-terminus, which contains the phosphorylation sites
for protein kinase C (PKC) and cAMP-dependent
protein kinase (PKA) [14^18]. In contrast to other
swelling-activated anion channels where taurine
translocates with low permeability as compared to
Cl (Ptaurine=Cl 0.2^0.4 in MDCK cells and astrocytes)
[19,20] PLM channels reconstituted in lipid bilayer
have a selective permeability to taurine with a
Ptaurine=Cl of about 70 [9]. In fact, taurine was by
far, the most permeant compound from a long series
tested. PLM has been expressed in Xenopus oocytes
and this resulted in a large increase of taurine release
in response to hyposmotic solutions [9]. Interestingly,
PLM channels in lipid bilayers appear to have bind-
ing sites for cations and anions [21]. This particular
feature of PLM may represent an advantage for
translocation of a zwitterion as taurine and could
explain its high permeability through this channel.
To further investigate the involvement of PLM as a
pathway for taurine e¥ux activated by swelling and
its contribution to regulatory volume decrease
(RVD), in the present work we examined the proper-
ties of RVD, [3H]taurine and 125I e¥ux in two sub-
clones of the renal cell line human embryonic kidney
293 cells (HEK293) overexpressing stably transfected
canine PLM.
2. Methods
Fetal calf serum and penicillin/streptomycin were
obtained from GIBCO (Grand Island, NY, USA).
Trypsin, soybean trypsin inhibitor, DNase, insulin,
4,4P-diisothiocyanostilbene-2,2P-disulphonic acid
(DIDS), 1,9-dideoxy forskolin (DDF) and isoproter-
enol (ISO) were obtained from Sigma. (St Louis,
MO, USA). 5-Nitro-2-(3-phenylpropylamino)benzoic
acid (NPPB) and norepinephrine (NE), were pur-
chased from RBI (Natick, MD, USA). [3H]-Taurine
and 125I were from New England Nuclear (Boston,
MA, USA). All other chemicals were of the purest
grade available from regular commercial sources.
2.1. Cells and transfection
Control and transfected cells were kindly provided
by J.R. Miller, A.L. Tucker and J.R. Moorman
(University of Virginia, VA, USA) and were ob-
tained as described in [10], as follows. HEK293
were grown at a density of 3U105 cells per 35 mm
dish at 37‡ C in 5% CO2 in Dulbecco’s modi¢ed
Eagle’s medium with 10% fetal bovine serum, 2 mM
glutamine, 10 U/ml of penicillin and 50 Wg/ml of
streptomycin. After 24 h, when 50^80% con£uence
was reached by cultures, medium was replaced and
cells were transfected with lipofectamine (Life Tech-
nologies). The full-length canine cardiac PLM cDNA
was cloned into pcDNA3 (Invitrogen). One micro-
gram of DNA was placed in 100 Wl serum-free media
(Opti-MEM). Ten microliters of lipofectamine were
incubated in 100 Wl serum-free medium. The DNA
and lipofectamine solutions were combined and in-
cubated for 45 min. The mixture was made up to 1 ml
with serum-free medium and added to cells. Vesicle
fusion and DNA transfection was allowed to take
place in 5 h incubation. One mililiter growth media
(DMEM-F12) containing 20% fetal bovine serum
was added. The concentrations of DNA and lipofect-
amine used were optimized in a series of experiments
using transfection of the L-galactosidase gene di-
rected by a CMV promoter. The e⁄ciency of
transfection was quanti¢ed by incubating the cells
with X-Gal and counting the number of blue cells/
100 cells. The concentrations above yielded 20^30%
transfection e⁄ciency. A concentration of 1.6 mg/ml
resulted optimal according to a G418 killing curve,
showing a 95% of cell death in 5^7 days. Cells were
incubated for 7^10 days, when 50 colonies were
present. Ten colonies were isolated with cloning rings
and subcultured. Studies here reported were made in
parallel on two subclones C3 and C8, with trans-
fected PLM identi¢ed after sequencing the trans-
fected DNA, in cells with the empty vector (control)
and in native, non transfected cells (native).
2.2. Cell volume
Cell volume measurements were made as described
in Pasantes-Morales et al. (1994) [22]. Brie£y, cells
were detached by treatment for 2^3 min with phos-
phate-bu¡ered saline without calcium and containing
1 mM EDTA and 0.01% trypsin. Detached cells were
mixed with the same volume of serum-containing
medium, and then centrifuged and resuspended in
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isosmotic Krebs^HEPES medium. Then, an aliquot
of the cell suspension was diluted approximately
100-fold with media. Exactly 1 min later, cell volume
was measured at the indicated times using a Coulter
cell counter (model ZF) associated with a Coulter
channelizer (model 256). Cell volumes were measured
in picoliters but results were routinely expressed as
relative volume, i.e. the % of change with time over
the initial volume recorded in isosmotic medium.
RVD was analyzed as the % of regulation after
15 min as compared to isosmotic medium. HEPES-
bu¡ered isosmotic medium contained (in mM):
NaCl, 135; KCl, 5; MgSO4, 0.6; CaCl2, 1; glucose,
10; HEPES, 10; pH 7.4. The osmolarity calculated
was 300 mOsm/kg medium and was veri¢ed using an
osmometer (Osmette A Automatic). Hyposmotic so-
lutions were always prepared by reducing the concen-
tration of NaCl.
2.3. Release
For osmolyte release experiments [6^8] cultured
cells were loaded by incubation at 37‡C with either
[3H]-taurine (20^40 Ci/mmol; 1.0 WCi/ml) for 1 h in
the culture medium or 125I (17 Ci/mg; 2.5 WCi/ml) for
15 min in isosmotic medium. After loading, cells
were washed three times (5 min each) with isosmotic
medium. For [3H]taurine release experiments, cells
were ¢rst incubated for 5 min in isosmotic medium
and then for 5 min in 30% or 50% hyposmotic me-
dium. Results are expressed as the percent of radio-
activity released at each incubation period of the
total radioactivity accumulated by cells during load-
ing, excluding the washing period. For 125I e¥ux,
due to the larger release and lower retention of 125I
by cells, the release of 125I was measured by collect-
ing fractions every 20 s during 2.5 min in isosmotic
medium and 3.5 min in hyposmotic media. At the
end of the experiment, radioactivity in the collected
fractions and that remaining in cells were measured.
Results are expressed as described for taurine e¥ux.
In all parallel experiments control cells were treated
with the vehicle of the tested compounds.
2.4. Statistical analysis
Data were expressed as means þ S.E.M., and stat-
istical signi¢cance of the results was determined by
one-way analysis of variance (ANOVA) followed by
Fisher’s post-hoc test, with statistical signi¢cance set
at P6 0.05.
3. Results
3.1. Regulatory volume decrease
Experiments were carried out in two subclones (C3
and C8) of PLM-overexpressing cells and in parallel
with cells transfected with the empty vector (control).
In all cell types, exposure to solutions of decreased
osmolarity induced a rapid initial swelling of about
the same magnitude (Fig. 1A,B). In 30% hyposmotic
solutions, cell volume increased 42% in C3 and C8
cells and 46% in control cells (Fig. 1A). In 50% hy-
posmotic solutions the increase in cell volume ranged
76^79% (Fig. 1B). The peak swelling was attained
about 1 min after exposure to hyposmotic solutions
and immediately after, cells initiated an active RVD
tending to recover their original volume. In 30% hy-
posmotic solutions cells overexpressing PLM exhib-
ited a faster and more e⁄cient RVD during the ini-
tial phase of the process as compared to the controls
(Fig. 1A). In cells exposed to 50% hyposmotic solu-
tions, a signi¢cant increase in the e⁄ciency of RVD
was observed in both C3 and C8 cells as compared to
controls (Fig. 1B,D). After 15 min, C3 and C8 cells
recovered 76 and 67%, respectively, whereas control
cells recovered only 44% of the initial volume (Fig.
1D).
3.2. The e¥ux of osmolytes
3.2.1. Taurine e¥ux
Hyposmotic solutions stimulated the e¥ux of
[3H]taurine to an extent proportional to the decrease
in osmolarity. In 30% hyposmotic solutions,
[3H]taurine e¥ux from cells transfected with the
empty vector (control) and from native cells, in-
creased 12% over the basal level in isosmotic condi-
tions. Fig. 2A illustrates results from one clone of
control cells, but another clone of cells transfected
with the empty vector tested, gave essentially the
same results. In the C3 and C8 transfected cell
clones, the osmosensitive [3H]taurine e¥ux increased
to 16 and 23%, respectively (Fig. 2A). In 50% hypo-
BBAMCR 14613 5-4-00
M. Morales-Mulia et al. / Biochimica et Biophysica Acta 1496 (2000) 252^260254
smotic solutions, the observed di¡erences between
control and transfected cells were larger. [3H]taurine
release in control cells increased 34%, whereas the
enhancement in C3 cells was 50% and in C8 cells
was 68% (Fig. 2B). Taurine release in native cells
was slightly higher (not signi¢cant) than in controls
transfected with the empty vector (Fig. 2A,B).
[3H]Taurine release by 50% hyposmotic solutions in
other cells transfected with the empty vector (not
shown) was not signi¢cantly di¡erent from control
cells.
The e¡ect of PLM phosphorylation on the swell-
ing-induced taurine e¥ux, was examined following
the [3H]taurine e¥ux in 30% hyposmotic solution
from control and C3 cells treated with insulin or
with the L-adrenergic receptor agonists, ISO and
NE. In control cells, 10 WM ISO or 100 WM NE
increased the osmosensitive [3H]taurine release by
50^60%. Insulin (100 nM) was ine¡ective. In C3 cells
treatment with the L-adrenergic receptor agonists
was markedly higher, increasing the osmosensitive
e¥ux of [3H]taurine by 100%. In these cells, insulin
also increased [3H]taurine by 50% after treatment
with insulin (Fig. 2C,D). None of the agents
Fig. 1. Regulatory volume decrease in PLM-transfected cells. Cells were cultured as described in Section 2. For volume measurements,
cells were detached by treatment with Ca2-free saline containing 1 mM EDTA and 0.01% trypsin. The cell suspension was centri-
fuged and resuspended in a small volume of isosmotic medium. A sample of the cell suspension was diluted about 100-fold with iso-
smotic or hyposmotic media and 1 min after, cell volume was measured at the indicated times by electronic sizing. In A and B results
are expressed as % of change in volume taking cell volume in isosmotic conditions as the point of reference. In C and D results repre-
sent volume regulation, i.e. % of recovery of cell volume between minute 1 (maximal volume) and minute 15. (C) control cells ; C3
and C8, PLM-transfected cells. Results are means of 6^15 experiments with S.E.M. values shown as vertical bars. Asterisks indicate
statistically signi¢cant di¡erent from control (*P6 0.05).
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tested modi¢ed basal release of [3H]taurine (not
shown).
3.2.2. E¥ux of 125I
The e¥ux of Cl activated by hyposmolarity was
followed using 125I as tracer. Fig. 3A shows the time
course of 125I from control and from C3 and C8 cells
exposed to 30% hyposmotic solutions. In the trans-
fected cells 125I e¥ux increased from a basal value of
2^3% to a maximal of 14^16% at the peak release.
This was signi¢cantly higher than in the control cells,
where the peak e¥ux was 11.1%. In native cells the
maximal e¥ux reached was about 9% (Fig. 3A). 125I
released from cells with overexpressed PLM and
from non-transfected and native cells during the hy-
posmotic period is shown in Fig. 3B. The bars show
the percentage amount released in all fractions dur-
ing the exposure to the hyposmotic solution minus
the basal release in the fractions prior to stimulation.
The release from C3 and C8 cells was higher than in
control or native cells (Fig. 3B). In cells exposed to
50% hyposmotic solutions, no signi¢cant di¡erence
was found between control cells and those with over-
expressed PLM (results not shown).
The e¡ects of DDF, NPPB and DIDS, known
blockers of Cl channels, including those induced in
oocytes by PLM [4,6,8,16,23], were examined on
[3H]taurine and 125I e¥ux activated by swelling in
C3 and control cells. Table 1 shows the IC50 for these
compounds on [3H]taurine release. All blockers
Fig. 2. Release of [3H]taurine induced by hyposmolarity in PLM-transfected cells. Cells were loaded with [3H]taurine for 1 h and ra-
dioactivity release was measured as detailed in Section 2. After washing with isosmotic medium cells were incubated for 5 min with
isosmotic medium and 5 min with 30% (A) or 50% (B) hyposmotic medium. N, native cells ; C, control cells ; C3 and C8, PLM-trans-
fected cells. Results are expressed as the percent of radioactivity released at each incubation period of the total radioactivity accumu-
lated by cells during loading, excluding the washing period. In C and D cells were exposed to agents and drugs only during stimula-
tion with the 30% hyposmotic solution (ISO, 10 WM; NE, 100 WM; I, 100 nM insulin). Values are means þ S.E.M. of 11^16 separate
experiments. Asterisks indicate statistically signi¢cant di¡erent from control (*P6 0.05).
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tested exhibited a more potent e¡ect in cells with
PLM overexpressed. The largest di¡erence was found
for DDF, which exhibited an IC50 of 13.04 WM in
control cells as compared to 3.04 WM in C3 cells
(Table 1). All these blockers also markedly reduced
the osmosensitive release of 125I. Fig. 3C,D shows
that the osmosensitive 125I release induced by a
30% hyposmotic solution was completely inhibited
by DDF in both control and C3 cells. The inhibition
of 125I release by DIDS and NPPB was more pro-
nounced in C3 cells than in control cells (Fig. 3C,D).
DIDS reduced 125I e¥ux by 45 and 62% in control
Fig. 3. Release of 125I induced by hyposmolarity in PLM-transfected cells. Cells were cultured as described in Section 2 and loaded
with 125I for 15 min. Cells were washed with isosmotic medium. 125I release was measured by collecting fractions every 20 s during
2.5 min in isosmotic and 3.5 min in 30% hyposmotic media. In A,C and D results are expressed as the percent of 125I released at
each fraction of the total radioactivity accumulated by cells during loading, excluding the washing period. In B the results are the per-
centage amount released of 125I in all fractions during the exposure to the 30% hyposmotic solution minus the basal release in the
fractions prior to stimulation. N, native; C, control; C3 and C8, PLM-transfected cells. In C and D drugs were present during the
whole superfusion period (DIDS, 1 mM; NPPB, 100 WM; DDF, 100 WM). Values are means þ S.E.M. of 3^13 separate experiments.
Standard error bars were smaller than symbols when not shown. Asterisks indicate statistically signi¢cant di¡erent from control
(*P6 0.05).
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cells and C3 cells, respectively. NPPB inhibited 125I
release by 36 and 49% in control and C3 cells, re-
spectively.
4. Discussion
Results of the present work showed that HEK293
cells overexpressing PLM exhibit a faster and more
extensive RVD as well as an increase in the osmo-
sensitive £uxes of taurine and Cl. This provides some
evidence in support of an implication of PLM in the
mechanisms of cell volume control.
Non-transfected cells used in this work were able
to regulate cell volume and exhibited osmolyte re-
lease, despite their very low PLM content, indicating
the occurrence of native volume-activated anion/
taurine pathways. Noteworthy, the e¡ect of PLM
overexpression on RVD e⁄ciency was preferentially
observed under more stringent conditions of hypos-
molarity. The same e¡ect could be observed on the
e¥ux of taurine, i.e. the increase was greater in more
hyposmotic conditions while the e¥ux of Cl was
more increased in low hyposmotic conditions. These
results suggest a correlation between increased taur-
ine £uxes and more e⁄cient RVD upon overexpres-
sion of PLM. They may also suggest that PLM con-
tributes to the e⁄ciency of this process mainly under
conditions of excessive osmotic stress, which cannot
be handled by the preexisting channels.
It is unclear at present whether the presence of
PLM confers a more e⁄cient translocation of taurine
and Cl3 by forming a channel which transports the
osmolytes, or if PLM is acting as a regulator of al-
ready present channels [24^26]. This last possibility is
supported by evidence in insect cells, which natively
do not express PLM and cannot regulate cell volume,
but do not acquire this ability after experimental
PLM expression [27]. This suggests that PLM alone
is not su⁄cient for accomplishing RVD and the pres-
ence of other channels is necessary. In further sup-
port of a regulatory action of PLM, we found that
expression of PLM confers the taurine and Cl trans-
port pathway a higher sensitivity to drugs such as
DIDS, DDF, and NPPB. These Cl channel blockers
decreased taurine and Cl e¥ux in HEK293 as they
do in the PLM currents expressed in oocytes [23], but
in PLM overexpressing cells both taurine and Cl
£uxes were notably more sensitive to these blockers.
This change re£ects not only an e¡ect of this agents
on PLM but possibly in the endogenous anion/tau-
rine pathway as well. Altogether, these results sug-
gest that, apart form its ability to form a pore, PLM
may act as regulator of volume sensitive channels. It
is worthy to notice that there is evidence showing
that Cl currents triggered by hyposmolarity can be
modulated by other structurally di¡erent osmosensi-
tive Cl channels [28]. Moreover, heterologous, native
or not native proteins [29,30] modify non-osmosensi-
tive Cl conductance. The mechanism of this Cl chan-
nel modulation is not clearly understood. It is un-
known whether the expressed proteins results from
a direct or an indirect e¡ect on the channel molecule.
This can be true also for the e¡ects of the overex-
pressed PLM described in the present work.
When PLM is expressed in Xenopus oocytes, a
non-inactivating anion selective current is induced
upon hyperpolarization [23,31]. Also, incorporation
of PLM in lipid bilayers generates an anion-selective
current [9] exhibiting no closures during a voltage
ramp extending from 350 to +50 mV [32]. In a vari-
ety of cells, particularly in epithelial cells, the ¢rst
event evoked by swelling is the activation of K £uxes
resulting in hyperpolarization and it is only after-
wards that Cl channels activate [33]. The PLM acti-
vation as consequence of this hyperpolarization may
contribute with taurine and Cl £uxes to RVD.
It has previously been demonstrated that PLM
shows consensus sequences for phosphorylation [18]
Table 1
E¡ects of Cl channel blockers on the volume-activated taurine
e¥ux from PLM overexpressing and control cells
Drugs IC50 (WM)
Control C3
DDF 13.21 (10.3^14.3) 3.04 (1.4^6.3)
NPPB 10.09 (9.0^12.5) 6.03 (4.1^9.0)
DIDS 87.38 (65.2^118.4) 30.71 (20.8^55.3)
Cells were loaded with [3H]taurine for 1 h and radioactivity re-
lease was measured as detailed in Section 2. After washing with
isosmotic medium, cells were incubated for 5 min with iso-
smotic medium and 5 min with 30% hyposmotic medium. Cells
were preincubated 10 min with drugs, which were also present
during the entire release experiment. Data are half maximal in-
hibitory (IC50) concentration values (means, with 95% con¢-
dence intervals in parentheses) of at least three separate experi-
ments, analyzed by the GraphPad Inplot Program.
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and is substrate for PKC and PKA. Accordingly,
insulin and K- and L-adrenergic receptor agonists
phosphorylate PLM [14^18]. The physiological sig-
ni¢cance of PLM phosphorylation is still unknown
but interestingly, the present study showed an in-
creased osmosensitive e¥ux of taurine by these phos-
phorylating agents particularly in cells with trans-
fected PLM. Thus, phosphorylated PLM may a¡ect
taurine £uxes either by directly increasing its own
e⁄ciency as a channel or indirectly by modulating
other preexisting channels. The di¡erences observed
between insulin and the adrenergic agonists suggest
PKA is more e⁄cient in phosphorylating PLM.
Transfected PLM a¡ected taurine more than Cl
£uxes. This may be explained by the unique perme-
ability properties of this channel. In contrast to other
swelling-activated anion channels, which permeate
taurine with low permeability as compared to Cl
(Ptaurine=Cl 0.2^0.4) [19,20] PLM has a selective per-
meability to taurine with a Ptaurine=Cl of about 70 [9].
In fact, taurine was by far, the most permeant anion
from a long series tested. A PLM feature that may
explain this high taurine permeability is the existence
of binding sites for cations and anions within the
pore [21]. Since taurine is a zwitterion, this property
of PLM represents an advantage for its transport.
In conclusion our ¢ndings support the idea that
PLM plays a role in the process of RVD as evi-
denced by the increase of taurine release in PLM
overexpressing cells and the potentiation of these re-
lease by agents phosphorylating this channel. The
mechanisms involved in this process could include
the activation of PLM itself as channel or the mod-
ulation of other preexisting channels.
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